Resultados da busca - Amer Al‐Karadsheh
- Mostrando 1 - 2 resultados de 2
-
1
Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, ph... por Matthias von Herrath, Stephen C. Bain, Bruce W. Bode, Jesper O. Clausen, Ken Coppieters, Leyla Gaysina, Janusz Gumprecht, Troels Krarup Hansen, Chantal Mathieu, Cristóbal Morales, Ofri Mosenzon, Stine Segel, George Tsoukas, Thomas R. Pieber, Bernhard Ludvik, Rudolf Prager, Bernhard Paulweber, Christoph Ebenbichler, Bart Keymeulen, Christophe De Block, Loren D. Grossman, Robyn L. Houlden, Patrice Perron, Thomas Ransom, Peter Senior, S. John Weisnagel, Vincent Woo, R Dumas, David Thompson, Tina Vilsbøll, Jeppe Gram, Claus Bogh Juhl, Janne Hukkanen, Jorma Lahtela, Leo Niskanen, Donal O’Shea, Timothy O’Brien, Séamus Sreenan, Julio Wainstein, Moshe Phillip, Hilla Knobler, Francesco Dotta, Pier Marco Piatti, Roberto Trevisan, Agostino Gnasso, Hanne L. Gulseth, John Cooper, Ewa Pańkowska, Monika Łukaszewicz, Bogumił Wolnik, Isabel Manita, Olinda Marques, Cristina Roque, Rosa Maria Príncipe, Celestino Neves, Susana Heitor, L. A. Ruyatkina, I. V. Dvoryashina, Gulnar Vagapova, Lidiya Belousova, M. Sergeeva-Kondrachenko, А. Б. Песков, Elena Frolova, Albina Golovach, М. А. Куницына, N Krasnopeeva, Irina Ipatko, Carmen de la Cuesta Benjumea, Francisco J. Tinahones, Mercedes Rigla, Juan Francisco Merino-Torres, Luis Alberto Gómez, Mercè Fernández, Rafael Simó, Mikael Rydén, Johan Jendle, Karin Filipsson, Björn Eliasson, Boris Mankovsky, Iurii Lymar, Liubov Sokolova, Galyna Myshanych, Tetiana Zlova, М.V. Vlasenkо, Petro Kuskalo -, Hamish Courtney, Colin Dayan, Patrick English, Simon Heller, A.B. Johnson, Sunil Nair, Richard David Leslie, Parth Narendran, Nick Oliver, Shenaz Ramtoola, J. H. F. Shaw, Adie Viljoen, Amer Al‐Karadsheh, Jean M. Dostou, Sumana Gangi
Publicado em 2021Artigo -
2
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial por W. Timothy Garvey, Juan P. Frías, Ania M. Jastreboff, Carel W. le Roux, Naveed Sattar, Diego Aizenberg, Huzhang Mao, Shuyu Zhang, Nadia N. Ahmad, Mathijs C. Bunck, Imane Benabbad, X. Zhang, Franklin Ábalos, Federico C. Pérez Manghi, Cesar Javier Zaidman, Marisa L. Vico, Diego Aizenberg, P. Costanzo, L. Serra, Ignacio MacKinnon, Miguel Nasser Hissa, Maria H Vidotti, José Francisco Kerr Saraiva, Breno B. Alves, Denise Reis Franco, Otavio Moratto, Sreenivasa Murthy, Ghanshyam Goyal, Yoshimitsu Yamasaki, Nobuyuki Sato, Satoshi Inoue, Taro Asakura, Marina V. Shestakova, Elena Khaykina, Е. А. Трошина, Н. В. Ворохобина, Ametov As, Shih‐Te Tu, Chwen-Yi Yang, I‐Te Lee, Chien‐Ning Huang, Horng‐Yih Ou, George Freeman, Sriram Machineni, Klara R. Klein, Senan Sultan, Alan A. Parsa, Juan Otero-Martinez, Alex Gonzalez, Anuj Bhargava, Susan Brian, Carlos Ince, Stephen Plantholt, Jeremy Cole, Audrey Lacour, Damaris Vega, José de Souza, Jane L. Rohlf, Roy C. St. John, Barry Horowitz, Hanid Audish, Rodolfo J. Galindo, Guillermo Umpiperrez, Jamy D. Ard, Brian R. Curtis, W. Timothy Garvey, Neil J. Fraser, Jose Mandry, Rizwana Mohseni, Ronald K. Mayfield, Talessa Powell, Carl Vance, Stephen Ong, Ana L. Lewy-Alterbaum, Alexander V. Murray, Amer Al‐Karadsheh, Tamer Yacoub, Kevin Roberts, David L. Fried, Julio Rosenstock, Bharathi Pulla, Bruce W. Bode, Juan P. Frías, Leslie J. Klaff, Ronald Brazg, Joanna Van, Anjanette Tan, Toby Briskin, Margaret Rhee, Tira Chaicha-Brom, Paul Hartley, Lazaro Nunez, Gregorio Cortes-Maisonet, Gary Soucie, Stanley H. Hsia, Thomas C. Jones
Publicado em 2023Artigo
Ferramentas de busca:
Assuntos relacionados
Alternative medicine
Diabetes mellitus
Endocrinology
Internal medicine
Medicine
Pathology
Placebo
Type 2 diabetes
Antibody
Body mass index
Clinical endpoint
Discontinuation
Environmental health
Immunology
Intention-to-treat analysis
Liraglutide
Obesity
Overweight
Physical therapy
Population
Randomized controlled trial
Regimen
Weight loss